New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines

@article{Chouinard1983NewCI,
  title={New concepts in benzodiazepine therapy: Rebound anxiety and new indications for the more potent benzodiazepines},
  author={Guy Chouinard and Anne Labont{\'e} and R{\'e}jean Fontaine and Lawrence Annable},
  journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry},
  year={1983},
  volume={7},
  pages={669-673}
}
  • Guy Chouinard, Anne Labonté, +1 author Lawrence Annable
  • Published 1983
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • Abrupt withdrawal of benzodiazepine treatment in generalized anxiety patients was found to induce a rebound anxiety state in addition to minor physical symptoms. Controlled clinical trials suggest that the newer high potency benzodiazepines (alprazolam, clonazepam and bromazepam) have novel psychiatric indications and greater anxiolytic effect than the classical benzodiazepines. Alprazolam, a triazolobenzodiazepine, was superior to placebo in the treatment of panic disorder, for which medium or… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 17 CITATIONS

    A Guide to Benzodiazepine Selection. Part II: Clinical Aspects

    Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder

    VIEW 3 EXCERPTS
    CITES BACKGROUND

    Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Comorbid Anxiety in Bipolar Disorder Alters Treatment and Prognosis

    VIEW 1 EXCERPT
    CITES BACKGROUND